Ann: Trading Halt, page-37

Even though the CR was a sure fire event, as posted above it's for progression of the company so generally a positive.

Not sure buying out a company that a director owns / founder etc for $30M is best idea (could be seen as filling own pockets) & completely transparent as I've seen out there, especially when in this case Althea has Alphria by their side in Canada where this Peak Processing company from. I read they seem to be in rec space. Anyway follow this one as details emerge.

Doesn't sit overly well with me as I see Althea very much in the helping patients medical space & this does a 180.

Then I'm a non-holder so no matter.

Those crying no SPP offered to retail holders, maybe just buy on market as SP likely to get closer to the stated $1 CR.

Nothing wrong with gaining some traction in Canada though.